JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.
Doing business as JUBILANT RADIOPHARMA
- ORLANDO, FL 32811-6628
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $6.3M
- Awards on record
- 28
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
JUBILANT DRAXIMAGE RADIOPHARMACIES, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.
- Headquarters
- ORLANDO, FL 32811-6628
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIEQ4VSLH8RC33
- CAGE7XH67
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $6.3M
- Awards on record
- 28
- Top funding agencies
- Department of Veterans Affairs · Defense Health Agency
25 most recent of 28 awards
36C24826N0411
Recompete < 6 mo: Potential end Mar 14, 2027 (4 months away)RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE
Department of Veterans Affairs
- Obligated
- $231.8K
- Period of performance
- Mar 15, 2026 – Mar 14, 2027
36C25226N0210
Recompete < 6 mo: Potential end Jan 31, 2027 (2 months away)RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $165K
- Period of performance
- Feb 1, 2026 – Jan 31, 2027
36C24126N0274
Recompete < 6 mo: Potential end Jan 29, 2027 (2 months away)RADIOPHARMS ORDER
Department of Veterans Affairs
- Obligated
- $771.4K
- Period of performance
- Jan 30, 2026 – Jan 29, 2027
36C26126N0065
Completed: Period of performance ended Sep 30, 2026SF RADIOPHARM OP5
Department of Veterans Affairs
- Obligated
- $154K
- Period of performance
- Oct 1, 2025 – Sep 30, 2026
36C24825N0208
Completed: Period of performance ended Mar 14, 2026RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE
Department of Veterans Affairs
- Obligated
- $138.9K
- Period of performance
- Mar 15, 2025 – Mar 14, 2026
36C24722P0498
Completed: Period of performance ended Feb 28, 2026CU-64 DOTATATE RADIO-PHARMACEUTICAL
Department of Veterans Affairs
- Obligated
- $681.5K
- Period of performance
- Mar 1, 2022 – Feb 28, 2026
36C24125N0495
Completed: Period of performance ended Feb 6, 2026RADIOPHARMS
Department of Veterans Affairs
- Obligated
- $656.9K
- Period of performance
- Feb 7, 2025 – Feb 6, 2026
36C25225N0230
Completed: Period of performance ended Jan 31, 2026RADIPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $150.6K
- Period of performance
- Feb 1, 2025 – Jan 31, 2026
HT001422P0007
Completed: Period of performance ended Jan 14, 2026MERTIATIDE MAG3, COMPOUNDED R057A0 I-131 CAPSULES.
Department of Defense · Defense Health Agency
- Obligated
- $251.6K
- Period of performance
- Oct 22, 2021 – Jan 14, 2026
36C24120P0077
Completed: Period of performance ended Dec 31, 2025RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $383.9K
- Period of performance
- Nov 1, 2019 – Dec 31, 2025
36C24124N0377
Completed: Period of performance ended Dec 11, 2025RADIOPHARM SUPPLIES
Department of Veterans Affairs
- Obligated
- $412.1K
- Period of performance
- Feb 1, 2024 – Dec 11, 2025
36C26125N0003
Completed: Period of performance ended Sep 30, 2025NUCLEAR RADIOPHARMACEUTICALS MEDICINE OP 4
Department of Veterans Affairs
- Obligated
- $66.8K
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
36C25224N0282
Completed: Period of performance ended Mar 31, 2025RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $149.8K
- Period of performance
- Apr 1, 2024 – Mar 31, 2025
36C24824N0388
Completed: Period of performance ended Mar 14, 2025RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE
Department of Veterans Affairs
- Obligated
- $210K
- Period of performance
- Mar 15, 2024 – Mar 14, 2025
36C26124N0005
Completed: Period of performance ended Sep 30, 2024NUCLEAR RADIOPHARMACEUTICALS MEDICINE
Department of Veterans Affairs
- Obligated
- $71.4K
- Period of performance
- Oct 1, 2023 – Sep 30, 2024
36C24420P0041
Completed: Period of performance ended Sep 30, 2024RADIOPHARMAECUTICAL CONTRACT
Department of Veterans Affairs
- Obligated
- $728.8K
- Period of performance
- Oct 1, 2019 – Sep 30, 2024
36C24719P0682
Completed: Period of performance ended Apr 30, 2024RADIOPHARMACEUTICAL DELIVERIES
Department of Veterans Affairs
- Obligated
- $291K
- Period of performance
- May 1, 2019 – Apr 30, 2024
36C25223N0339
Completed: Period of performance ended Mar 31, 2024RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $93.4K
- Period of performance
- Apr 1, 2023 – Mar 31, 2024
36C25222N0310
Completed: Period of performance ended Mar 27, 2024RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $93.9K
- Period of performance
- Apr 1, 2022 – Mar 27, 2024
36C24823N0377
Completed: Period of performance ended Mar 14, 2024RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE
Department of Veterans Affairs
- Obligated
- $189K
- Period of performance
- Mar 15, 2023 – Mar 14, 2024
36C24123N0363
Completed: Period of performance ended Jan 31, 2024ORDER FOR RADIOPHARMS
Department of Veterans Affairs
- Obligated
- $378.5K
- Period of performance
- Feb 1, 2023 – Jan 31, 2024
36C24623N1129
Completed: Period of performance ended Dec 31, 2023JUBILANT RADIOPHARMACEUTICALS
Department of Veterans Affairs
- Obligated
- $39.7K
- Period of performance
- Sep 29, 2023 – Dec 31, 2023
36C26123N0170
Completed: Period of performance ended Sep 30, 2023NUCLEAR RADIOPHARMACEUTICALS MEDICINE ORDER
Department of Veterans Affairs
- Obligated
- $80K
- Period of performance
- Oct 1, 2022 – Sep 30, 2023
36C25022N0320
Completed: Period of performance ended Apr 26, 2023RADIOPHARMACEUTICALS - OPTION YEAR 2
Department of Veterans Affairs
- Obligated
- $124.7K
- Period of performance
- Apr 27, 2022 – Apr 26, 2023
36C24822N0383
Completed: Period of performance ended Mar 14, 2023GALLIUM GA68 RADIOPHARMACEUTICAL FOR PET
Department of Veterans Affairs
- Obligated
- $165K
- Period of performance
- Mar 16, 2022 – Mar 14, 2023
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C24826N0411 under 36C24822D0048 RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $231.8K | Mar 15, 2026 – Mar 14, 2027 | Recompete < 6 mo: Potential end Mar 14, 2027 (4 months away)AI brief for award 36C24826N0411Bid team for the recompete of award 36C24826N0411 |
36C25226N0210 under 36C25225D0021 RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $165K | Feb 1, 2026 – Jan 31, 2027 | Recompete < 6 mo: Potential end Jan 31, 2027 (2 months away)AI brief for award 36C25226N0210Bid team for the recompete of award 36C25226N0210 |
36C24126N0274 under 36C24121A0025 RADIOPHARMS ORDER | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $771.4K | Jan 30, 2026 – Jan 29, 2027 | Recompete < 6 mo: Potential end Jan 29, 2027 (2 months away)AI brief for award 36C24126N0274Bid team for the recompete of award 36C24126N0274 |
36C26126N0065 under 36C26122D0063 SF RADIOPHARM OP5 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $154K | Oct 1, 2025 – Sep 30, 2026 | Completed: Period of performance ended Sep 30, 2026 |
36C24825N0208 under 36C24822D0048 RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $138.9K | Mar 15, 2025 – Mar 14, 2026 | Completed: Period of performance ended Mar 14, 2026 |
36C24722P0498 CU-64 DOTATATE RADIO-PHARMACEUTICAL | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $681.5K | Mar 1, 2022 – Feb 28, 2026 | Completed: Period of performance ended Feb 28, 2026 |
36C24125N0495 under 36C24121A0025 RADIOPHARMS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $656.9K | Feb 7, 2025 – Feb 6, 2026 | Completed: Period of performance ended Feb 6, 2026 |
36C25225N0230 under 36C25225D0021 RADIPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $150.6K | Feb 1, 2025 – Jan 31, 2026 | Completed: Period of performance ended Jan 31, 2026 |
HT001422P0007 MERTIATIDE MAG3, COMPOUNDED R057A0 I-131 CAPSULES. | Department of Defense · Defense Health Agency | 339112 · 6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $251.6K | Oct 22, 2021 – Jan 14, 2026 | Completed: Period of performance ended Jan 14, 2026 |
36C24120P0077 RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $383.9K | Nov 1, 2019 – Dec 31, 2025 | Completed: Period of performance ended Dec 31, 2025 |
36C24124N0377 under 36C24121A0025 RADIOPHARM SUPPLIES | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $412.1K | Feb 1, 2024 – Dec 11, 2025 | Completed: Period of performance ended Dec 11, 2025 |
36C26125N0003 under 36C26122D0063 NUCLEAR RADIOPHARMACEUTICALS MEDICINE OP 4 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $66.8K | Oct 1, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C25224N0282 under 36C25222D0030 RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $149.8K | Apr 1, 2024 – Mar 31, 2025 | Completed: Period of performance ended Mar 31, 2025 |
36C24824N0388 under 36C24822D0048 RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $210K | Mar 15, 2024 – Mar 14, 2025 | Completed: Period of performance ended Mar 14, 2025 |
36C26124N0005 under 36C26122D0063 NUCLEAR RADIOPHARMACEUTICALS MEDICINE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $71.4K | Oct 1, 2023 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
36C24420P0041 RADIOPHARMAECUTICAL CONTRACT | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $728.8K | Oct 1, 2019 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
36C24719P0682 RADIOPHARMACEUTICAL DELIVERIES | Department of Veterans Affairs | 325412 · Q527MEDICAL- NUCLEAR MEDICINE | $291K | May 1, 2019 – Apr 30, 2024 | Completed: Period of performance ended Apr 30, 2024 |
36C25223N0339 under 36C25222D0030 RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $93.4K | Apr 1, 2023 – Mar 31, 2024 | Completed: Period of performance ended Mar 31, 2024 |
36C25222N0310 under 36C25222D0030 RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $93.9K | Apr 1, 2022 – Mar 27, 2024 | Completed: Period of performance ended Mar 27, 2024 |
36C24823N0377 under 36C24822D0048 RADIOPHARMACEUTICAL-GALLIUM 68 DOTATATE | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $189K | Mar 15, 2023 – Mar 14, 2024 | Completed: Period of performance ended Mar 14, 2024 |
36C24123N0363 under 36C24121A0025 ORDER FOR RADIOPHARMS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $378.5K | Feb 1, 2023 – Jan 31, 2024 | Completed: Period of performance ended Jan 31, 2024 |
36C24623N1129 under 36C24619D0019 JUBILANT RADIOPHARMACEUTICALS | Department of Veterans Affairs | 325412 · 6640LABORATORY EQUIPMENT AND SUPPLIES | $39.7K | Sep 29, 2023 – Dec 31, 2023 | Completed: Period of performance ended Dec 31, 2023 |
36C26123N0170 under 36C26122D0063 NUCLEAR RADIOPHARMACEUTICALS MEDICINE ORDER | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $80K | Oct 1, 2022 – Sep 30, 2023 | Completed: Period of performance ended Sep 30, 2023 |
36C25022N0320 under 36C25020D0057 RADIOPHARMACEUTICALS - OPTION YEAR 2 | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $124.7K | Apr 27, 2022 – Apr 26, 2023 | Completed: Period of performance ended Apr 26, 2023 |
36C24822N0383 under 36C24822D0048 GALLIUM GA68 RADIOPHARMACEUTICAL FOR PET | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $165K | Mar 16, 2022 – Mar 14, 2023 | Completed: Period of performance ended Mar 14, 2023 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimarySmall business under this code’s size standard
- 325411Title not in the curated listSmall business under this code’s size standard
SAM.gov reports this entity as small under 2 of 2 NAICS codes. Size is determined per code (SBA size standards).
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with JUBILANT DRAXIMAGE RADIOPHARMACIES, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.